China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
SAN FRANCISCO, March 17, 2017 -- BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 27th Annual Oppenheimer Healthcare Conference to be held in New York City on March 21st and 22nd, 2017.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, March 22nd at 2:45 p.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.
Company Contact Information: Josh Kriesel President and CEO +1-415-336-6496 Ron Pauli Chief Financial Officer +1-415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc. (ICR) +1-646-277-1282
